메뉴 건너뛰기




Volumn 130, Issue 11, 2003, Pages 1025-1031

Molecular markers associated to prognosis of melanoma;Marqueurs moléculaires associés au pronostic du mélanome

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; BETA2 INTEGRIN; BETA3 INTEGRIN; CYCLIN A; CYCLIN D; GELATINASE A; HERMES ANTIGEN; KI 67 ANTIGEN; MELAN A; MOLECULAR MARKER; NM 23 PROTEIN; OSTEONECTIN; PROTEIN; PROTEIN P16; PROTEIN P27; PROTEIN P35; UNCLASSIFIED DRUG;

EID: 0347379997     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (13)

References (79)
  • 3
    • 0031739852 scopus 로고    scopus 로고
    • Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm)
    • Spatz A, Shaw HM, Crotty KA, Thompson JE, McCarthy SW. Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm). Histopathology 1998;33:406-13.
    • (1998) Histopathology , vol.33 , pp. 406-413
    • Spatz, A.1    Shaw, H.M.2    Crotty, K.A.3    Thompson, J.E.4    McCarthy, S.W.5
  • 4
    • 0033015462 scopus 로고    scopus 로고
    • Update of diagnostic and prognostic markers in cutaneous malignant melanoma
    • Reed JA, Albino AP. Update of diagnostic and prognostic markers in cutaneous malignant melanoma. Dermatol Clin 1999;17:631-43.
    • (1999) Dermatol Clin , vol.17 , pp. 631-643
    • Reed, J.A.1    Albino, A.P.2
  • 5
    • 0032794632 scopus 로고    scopus 로고
    • Cell cycle regulators: Mechanism and their role in aetiology, prognosis and treatment of cancer
    • Michalides RJAM. Cell cycle regulators: mechanism and their role in aetiology, prognosis and treatment of cancer. J Clin Pathol 1999;52:555-68.
    • (1999) J Clin Pathol , vol.52 , pp. 555-568
    • Michalides, R.J.A.M.1
  • 6
    • 0030866223 scopus 로고    scopus 로고
    • Multiple pathways control cell cycle growth and transformation overlapping and independent activities of p53 and p21
    • Cox LS. Multiple pathways control cell cycle growth and transformation overlapping and independent activities of p53 and p21. J Pathol 1997;183:134-40.
    • (1997) J Pathol , vol.183 , pp. 134-140
    • Cox, L.S.1
  • 7
    • 0030051787 scopus 로고    scopus 로고
    • Expression of cyclin D1 and p53 in various malignant skin tumours
    • Inohara S, Kitagawa K, Kitano Y. Expression of cyclin D1 and p53 in various malignant skin tumours. Dermatology 1996;192:94-8.
    • (1996) Dermatology , vol.192 , pp. 94-98
    • Inohara, S.1    Kitagawa, K.2    Kitano, Y.3
  • 8
    • 0030040533 scopus 로고    scopus 로고
    • Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma
    • Wang YL, Uhara H, Yamazaki Y, Nikaido T, Saida T. Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma. Br J Dermatol 1996;134:269-75.
    • (1996) Br J Dermatol , vol.134 , pp. 269-275
    • Wang, Y.L.1    Uhara, H.2    Yamazaki, Y.3    Nikaido, T.4    Saida, T.5
  • 9
    • 0029044648 scopus 로고
    • Expression of p53 protein in malignant melanoma: Clinicopathological and prognostic implications
    • Weiss J, Heine M, Korner B, Pilch H, Jung EC. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications. Br J Dermatol 1995;733:23-31.
    • (1995) Br J Dermatol , vol.733 , pp. 23-31
    • Weiss, J.1    Heine, M.2    Korner, B.3    Pilch, H.4    Jung, E.C.5
  • 10
    • 0031851739 scopus 로고    scopus 로고
    • Protein expression of the cell cycle inhibitor p27Kip1 in malignant melanoma: Inverse correlation with disease-free interval
    • Florenes VA, Maelandsmo GM, Kerbel RS, Slingerland JM, Nesland JM, Hom R. Protein expression of the cell cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free interval. Am J Pathol 1998;153:305-12.
    • (1998) Am J Pathol , vol.153 , pp. 305-312
    • Florenes, V.A.1    Maelandsmo, G.M.2    Kerbel, R.S.3    Slingerland, J.M.4    Nesland, J.M.5    Hom, R.6
  • 11
    • 0029805005 scopus 로고    scopus 로고
    • Cyclin kinase inhibitor p21WAF/CIP1 in malignant melanoma: Reduced expression in metastatic lesions
    • Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Florenes VA. Cyclin kinase inhibitor p21WAF/CIP1 in malignant melanoma: reduced expression in metastatic lesions. Am J Pathol 1996;149:1813-22.
    • (1996) Am J Pathol , vol.149 , pp. 1813-1822
    • Maelandsmo, G.M.1    Holm, R.2    Fodstad, O.3    Kerbel, R.S.4    Florenes, V.A.5
  • 12
    • 0033067733 scopus 로고    scopus 로고
    • P21 (WAF1/CIP1) expression in stage I cutaneous melanoma: Its relationship with p53, cell proliferation and survival
    • Karjalainen JM, Eskelinen MJ, Kellokoski JK, Reinikainen M, Alhava EM, Kosma VM. P21 (WAF1/CIP1) expression in stage I cutaneous melanoma: its relationship with p53, cell proliferation and survival. Br J Cancer 1999;79:895-902.
    • (1999) Br J Cancer , vol.79 , pp. 895-902
    • Karjalainen, J.M.1    Eskelinen, M.J.2    Kellokoski, J.K.3    Reinikainen, M.4    Alhava, E.M.5    Kosma, V.M.6
  • 13
    • 0030958766 scopus 로고    scopus 로고
    • Overexpression of the cyclin-dependant kinase inhibitor p21 (WAF1/CIP1) in human cutaneous malignant melanoma
    • Trotter MJ, Tang L, Tron VA. Overexpression of the cyclin-dependant kinase inhibitor p21 (WAF1/CIP1) in human cutaneous malignant melanoma. J Cutan Pathol 1997;24:265-71.
    • (1997) J Cutan Pathol , vol.24 , pp. 265-271
    • Trotter, M.J.1    Tang, L.2    Tron, V.A.3
  • 14
    • 0031594907 scopus 로고    scopus 로고
    • p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma
    • Funk JO, Schiller PL, Barrett MT, Wong DJ, Kind P, Sander CA. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma. J Cutan Pathol 1998;25:291-6.
    • (1998) J Cutan Pathol , vol.25 , pp. 291-296
    • Funk, J.O.1    Schiller, P.L.2    Barrett, M.T.3    Wong, D.J.4    Kind, P.5    Sander, C.A.6
  • 15
    • 0033560166 scopus 로고    scopus 로고
    • p16INK4a inactivation is not frequent in uncultered sporadic cutaneous melanoma
    • Fujimoto A, Morita R, Hatta N, Takehara K, Takata M. p16INK4a inactivation is not frequent in uncultered sporadic cutaneous melanoma. Oncogene 1999;15:2527-32.
    • (1999) Oncogene , vol.15 , pp. 2527-2532
    • Fujimoto, A.1    Morita, R.2    Hatta, N.3    Takehara, K.4    Takata, M.5
  • 16
    • 0031669830 scopus 로고    scopus 로고
    • Mitotic cyclins and cyclin-dependant kinases in melanocytic lesions
    • Tran TA, Ross JS, Carlson JA, Mihm MC Jr. Mitotic cyclins and cyclin-dependant kinases in melanocytic lesions. Hum Pathol 1998;29:1085-90.
    • (1998) Hum Pathol , vol.29 , pp. 1085-1090
    • Tran, T.A.1    Ross, J.S.2    Carlson, J.A.3    Mihm Jr., M.C.4
  • 17
    • 0029783806 scopus 로고    scopus 로고
    • Nuclear morphomey, immunohistochemical staining with Ki67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanoma of the skin
    • Talve LA, Collan YU, Elkfors TO. Nuclear morphomey, immunohistochemical staining with Ki67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanoma of the skin. J Cutan Pathol 1996;23:335-43.
    • (1996) J Cutan Pathol , vol.23 , pp. 335-343
    • Talve, L.A.1    Collan, Y.U.2    Elkfors, T.O.3
  • 19
    • 0029007357 scopus 로고
    • Cell proliferation markers in predicting metastases in malignant melanoma
    • Reddy VB, Gattuso P, Aranha G, Carson HJ. Cell proliferation markers in predicting metastases in malignant melanoma. J Cutan Pathol 1995;22:248-51.
    • (1995) J Cutan Pathol , vol.22 , pp. 248-251
    • Reddy, V.B.1    Gattuso, P.2    Aranha, G.3    Carson, H.J.4
  • 20
    • 0028894034 scopus 로고
    • Bcl2 protein expression in cutaneous malignant melanoma and benign melanocytic naevi
    • Cerroni L, Soyer HP, Kerl H. Bcl2 protein expression in cutaneous malignant melanoma and benign melanocytic naevi. Am J Dermatopathol 1995;17:7-11.
    • (1995) Am J Dermatopathol , vol.17 , pp. 7-11
    • Cerroni, L.1    Soyer, H.P.2    Kerl, H.3
  • 21
    • 0029044648 scopus 로고
    • Expression of p53 protein in malignant melanoma: Clinicopathological and prognostic implications
    • Weiss J, Heine M, Pilch H, Jung EG. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications. Br J Dermatol 1995;133:21-3.
    • (1995) Br J Dermatol , vol.133 , pp. 21-23
    • Weiss, J.1    Heine, M.2    Pilch, H.3    Jung, E.G.4
  • 22
    • 0032735232 scopus 로고    scopus 로고
    • Survivin apoptosis: An interloper between cell death and cell proliferation
    • Altieri DC, Marchisio PC, Marchisio C. Survivin apoptosis: An interloper between cell death and cell proliferation. Lab Invest 1999:79:1327-33.
    • (1999) Lab Invest , vol.79 , pp. 1327-1333
    • Altieri, D.C.1    Marchisio, P.C.2    Marchisio, C.3
  • 24
    • 0032887299 scopus 로고    scopus 로고
    • Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness
    • Kunz M, Hartmann A, Flory E, Tokso A, Koczan D, Thiessen HJ et al. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol 1999;155:753-63.
    • (1999) Am J Pathol , vol.155 , pp. 753-763
    • Kunz, M.1    Hartmann, A.2    Flory, E.3    Tokso, A.4    Koczan, D.5    Thiessen, H.J.6
  • 26
    • 0032929939 scopus 로고    scopus 로고
    • Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes
    • Ferrarini M, Imro MA, Sciorati C, Heltai S, Protti MP, Pellicari C et al. Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes. Int J Cancer 1999;81:573-9.
    • (1999) Int J Cancer , vol.81 , pp. 573-579
    • Ferrarini, M.1    Imro, M.A.2    Sciorati, C.3    Heltai, S.4    Protti, M.P.5    Pellicari, C.6
  • 30
    • 0029831503 scopus 로고    scopus 로고
    • Matrix metalloproteinase-2 (72 KD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
    • Vaisanen A, Tuominen H, Kallionien M, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (72 KD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 1996;180:283-9.
    • (1996) J Pathol , vol.180 , pp. 283-289
    • Vaisanen, A.1    Tuominen, H.2    Kallionien, M.3    Turpeenniemi-Hujanen, T.4
  • 31
    • 0032895321 scopus 로고    scopus 로고
    • Expression of collagenases-1 and 3 and their inhibitors TIMP-1 and 3 correlates with the level of invasion in malignant melanomas
    • Airola K, Karonen T, Vaalamo M, Lehti K, Kariniemi AL, Keski-Oja J et al. Expression of collagenases-1 and 3 and their inhibitors TIMP-1 and 3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999;80:733-43.
    • (1999) Br J Cancer , vol.80 , pp. 733-743
    • Airola, K.1    Karonen, T.2    Vaalamo, M.3    Lehti, K.4    Kariniemi, A.L.5    Keski-Oja, J.6
  • 32
    • 0033923006 scopus 로고    scopus 로고
    • Expression and activation of matrix metalloproteinases-2 (MMP-2) and its colocalization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression
    • Hofmann UB, Westphal JR, Zendman AJW, Becker JC, Ruiter D, Goos NP. Expression and activation of matrix metalloproteinases-2 (MMP-2) and its colocalization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J Pathol 2000;191:245-56.
    • (2000) J Pathol , vol.191 , pp. 245-256
    • Hofmann, U.B.1    Westphal, J.R.2    Zendman, A.J.W.3    Becker, J.C.4    Ruiter, D.5    Goos, N.P.6
  • 33
    • 0030884405 scopus 로고    scopus 로고
    • Expression of gelatinase B and the matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment lesions of the skin
    • van den Oord JJ, Paeme G, Opdenakker G, de Wolf-Peeters C. Expression of gelatinase B and the matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment lesions of the skin. Am J Pathol 1997;151:665-70
    • (1997) Am J Pathol , vol.151 , pp. 665-670
    • Van Den Oord, J.J.1    Paeme, G.2    Opdenakker, G.3    De Wolf-Peeters, C.4
  • 34
    • 0032911086 scopus 로고    scopus 로고
    • Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells
    • Takahashi K, Etoh H, Tananbe KK. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer 1999;80:387-95.
    • (1999) Int J Cancer , vol.80 , pp. 387-395
    • Takahashi, K.1    Etoh, H.2    Tananbe, K.K.3
  • 35
    • 0032926177 scopus 로고    scopus 로고
    • Localisation of matrix metalloproteinase-9 to the cell surface provides a mechanism for CD44 mediated tumour invasion
    • Yu Q, Stamenkovic J. Localisation of matrix metalloproteinase-9 to the cell surface provides a mechanism for CD44 mediated tumour invasion. Genes 1999;13:35-4.
    • (1999) Genes , vol.13 , pp. 35-34
    • Yu, Q.1    Stamenkovic, J.2
  • 38
    • 0029007805 scopus 로고
    • Expression of CD44 splice variants in human cutaneous melanoma cell lines is related to tumour progression and metastatic potential
    • Manten-Horst E, Danen EH, Smit L, Snoek M, Le Poole IC, Van Muijen GN et al. Expression of CD44 splice variants in human cutaneous melanoma cell lines is related to tumour progression and metastatic potential. Int J Cancer 1995;64:182-8.
    • (1995) Int J Cancer , vol.64 , pp. 182-188
    • Manten-Horst, E.1    Danen, E.H.2    Smit, L.3    Snoek, M.4    Le Poole, I.C.5    Van Muijen, G.N.6
  • 40
    • 0025012050 scopus 로고
    • Integrin distribution in malignant melanoma: Association of Β3 subunit with tumour progression
    • Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M et al. Integrin distribution in malignant melanoma: association of Β3 subunit with tumour progression. Cancer Res 1994;50:6757-64.
    • (1994) Cancer Res , vol.50 , pp. 6757-6764
    • Albelda, S.M.1    Mette, S.A.2    Elder, D.E.3    Stewart, R.4    Damjanovich, L.5    Herlyn, M.6
  • 41
    • 0030818746 scopus 로고    scopus 로고
    • The interaction of APC, E-cadherin and Βcatenin in tumour development and progression
    • Ilyas M, Tomlinson PM. The interaction of APC, E-cadherin and Βcatenin in tumour development and progression. J Pathol 1997;182:128-37.
    • (1997) J Pathol , vol.182 , pp. 128-137
    • Ilyas, M.1    Tomlinson, P.M.2
  • 42
    • 0034799321 scopus 로고    scopus 로고
    • Loss of beta-catenin expression associated with disease progression in malignant melanoma
    • Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T. Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 2001;145:210-6.
    • (2001) Br J Dermatol , vol.145 , pp. 210-216
    • Kageshita, T.1    Hamby, C.V.2    Ishihara, T.3    Matsumoto, K.4    Saida, T.5    Ono, T.6
  • 43
    • 0034492932 scopus 로고    scopus 로고
    • Reduced level of CD44 and hyaluronan associated with unfavourable prognosis in clinical stage I cutaneous melanoma
    • Karjalainen JM, Tammi RH, Eskelinen MJ, Agren VM, Parkkinen JJ, Alhava EM et al. Reduced level of CD44 and hyaluronan associated with unfavourable prognosis in clinical stage I cutaneous melanoma. Am J Pathol 2000;157:957-65.
    • (2000) Am J Pathol , vol.157 , pp. 957-965
    • Karjalainen, J.M.1    Tammi, R.H.2    Eskelinen, M.J.3    Agren, V.M.4    Parkkinen, J.J.5    Alhava, E.M.6
  • 44
    • 0030790353 scopus 로고    scopus 로고
    • High CD4-4 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival
    • Dietrich A, Tanczos E, Vanscheidt W, Schöpf E, Simon JC. High CD4-4 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. Eur J Cancer 1997;33:926-30.
    • (1997) Eur J Cancer , vol.33 , pp. 926-930
    • Dietrich, A.1    Tanczos, E.2    Vanscheidt, W.3    Schöpf, E.4    Simon, J.C.5
  • 46
    • 0027043136 scopus 로고
    • Tumour angiogenesis: A new, significant, and independent prognostic indicator of early stage melanoma
    • Weidner N, Folkman J, Pozza F, Belavicqua P, Allred E, Moore D et al. Tumour angiogenesis: a new, significant, and independent prognostic indicator of early stage melanoma. J Natl Cancer Inst 1992;84:1875-85.
    • (1992) J Natl Cancer Inst , vol.84 , pp. 1875-1885
    • Weidner, N.1    Folkman, J.2    Pozza, F.3    Belavicqua, P.4    Allred, E.5    Moore, D.6
  • 47
    • 0026636356 scopus 로고
    • Relation of neovascularization to metastatis of non-small-cell lung cancer
    • Macchiarini P, Fontanini G, Hardin M, Squartini F, Angletti C. Relation of neovascularization to metastatis of non-small-cell lung cancer. Lancet 1992;340:145-6.
    • (1992) Lancet , vol.340 , pp. 145-146
    • Macchiarini, P.1    Fontanini, G.2    Hardin, M.3    Squartini, F.4    Angletti, C.5
  • 48
    • 0027717345 scopus 로고
    • Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma
    • Weidner N, Carrol P, Flax J, Blumenfeld W, Folkman J. Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
    • (1993) Am J Pathol , vol.143 , pp. 401-409
    • Weidner, N.1    Carrol, P.2    Flax, J.3    Blumenfeld, W.4    Folkman, J.5
  • 49
    • 0028783602 scopus 로고
    • Tumour vascularity is not a prognostic factor for malignant melanoma of the skin
    • Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T et al. Tumour vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995;147:1049-56.
    • (1995) Am J Pathol , vol.147 , pp. 1049-1056
    • Busam, K.J.1    Berwick, M.2    Blessing, K.3    Fandrey, K.4    Kang, S.5    Karaoli, T.6
  • 51
    • 0028951043 scopus 로고
    • Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
    • Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:27-32.
    • (1995) Nat Med , vol.1 , pp. 27-32
    • Holmgren, L.1    O'Reilly, M.S.2    Folkman, J.3
  • 52
    • 0031929106 scopus 로고    scopus 로고
    • Tumour vascularity, proliferation and apoptosis in human melanoma micrometastases and macrometastases
    • Barnhill R, Piepkorn MW, Cochran AJ, Flynn E, Karaoli T, Folkman J. Tumour vascularity, proliferation and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol 1998;134:991-4.
    • (1998) Arch Dermatol , vol.134 , pp. 991-994
    • Barnhill, R.1    Piepkorn, M.W.2    Cochran, A.J.3    Flynn, E.4    Karaoli, T.5    Folkman, J.6
  • 53
    • 0035862187 scopus 로고    scopus 로고
    • Identification of the tumour metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome
    • Roymans D, Vissemberg K, DeJonghe Ch, Willems R, Engler G, Kimura N et al. Identification of the tumour metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome. Exptl Cell Res 2001;262:145-53.
    • (2001) Exptl Cell Res , vol.262 , pp. 145-153
    • Roymans, D.1    Vissemberg, K.2    DeJonghe, Ch.3    Willems, R.4    Engler, G.5    Kimura, N.6
  • 54
    • 0026457964 scopus 로고
    • Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression
    • Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 1992;52:6088-91.
    • (1992) Cancer Res , vol.52 , pp. 6088-6091
    • Florenes, V.A.1    Aamdal, S.2    Myklebost, O.3    Maelandsmo, G.M.4    Bruland, O.S.5    Fodstad, O.6
  • 55
    • 0031056656 scopus 로고    scopus 로고
    • Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
    • Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 1997;3:171-6.
    • (1997) Nat Med , vol.3 , pp. 171-176
    • Ledda, M.F.1    Adris, S.2    Bravo, A.I.3    Kairiyama, C.4    Bover, L.5    Chernajovsky, Y.6
  • 56
    • 0029164746 scopus 로고
    • MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas
    • Ramsay JA, From L, Iscoe NA, Kahn HJ. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas. J Invest Dermatol 1995;105:22-6.
    • (1995) J Invest Dermatol , vol.105 , pp. 22-26
    • Ramsay, J.A.1    From, L.2    Iscoe, N.A.3    Kahn, H.J.4
  • 57
    • 0031891403 scopus 로고    scopus 로고
    • Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors
    • Sparrow LE, English DR, Taran JM, Heenan PJ. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors. Am J Dermatopathol 1998;20:12-6.
    • (1998) Am J Dermatopathol , vol.20 , pp. 12-16
    • Sparrow, L.E.1    English, D.R.2    Taran, J.M.3    Heenan, P.J.4
  • 58
    • 0031975083 scopus 로고    scopus 로고
    • Prognostic implications of p53 overexpression in cutaneous melanomas from sun-exposed and non-exposed sites
    • Essner R, Kuo CT, Wang H, Wen DR, Turner RR, Nguyen T et al. Prognostic implications of p53 overexpression in cutaneous melanomas from sun-exposed and non-exposed sites. Cancer 1998;82:309-16.
    • (1998) Cancer , vol.82 , pp. 309-316
    • Essner, R.1    Kuo, C.T.2    Wang, H.3    Wen, D.R.4    Turner, R.R.5    Nguyen, T.6
  • 59
    • 0032587495 scopus 로고    scopus 로고
    • p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
    • Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999;154:313-23.
    • (1999) Am J Pathol , vol.154 , pp. 313-323
    • Lloyd, R.V.1    Erickson, L.A.2    Jin, L.3    Kulig, E.4    Qian, X.5    Cheville, J.C.6
  • 60
    • 0030659080 scopus 로고    scopus 로고
    • Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma
    • Strauma O, Akselen LA. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int J Cancer 1997;74:535-9.
    • (1997) Int J Cancer , vol.74 , pp. 535-539
    • Strauma, O.1    Akselen, L.A.2
  • 61
    • 0034103810 scopus 로고    scopus 로고
    • Loss of nuclear p16 expression correlates with increased tumour cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma
    • Strauma O, Sviland L, Akselen LA. Loss of nuclear p16 expression correlates with increased tumour cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Clin Cancer Res 2000;6:1845-53.
    • (2000) Clin Cancer Res , vol.6 , pp. 1845-1853
    • Strauma, O.1    Sviland, L.2    Akselen, L.A.3
  • 62
    • 0035668485 scopus 로고    scopus 로고
    • Cyclin A expression in superficial spreading melanomas correlates with clinical outcome
    • Florenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R. Cyclin A expression in superficial spreading melanomas correlates with clinical outcome. J Pathol 2001;195:530-6.
    • (2001) J Pathol , vol.195 , pp. 530-536
    • Florenes, V.A.1    Maelandsmo, G.M.2    Faye, R.3    Nesland, J.M.4    Holm, R.5
  • 63
    • 0033822962 scopus 로고    scopus 로고
    • Levels of Cyclin D1 and D3 in malignant melanoma. Deregulated Cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
    • Florenes VA, Faye RS, Maelandsmo GM, Nesland JM, Holm R. Levels of Cyclin D1 and D3 in malignant melanoma. Deregulated Cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin Cancer Res 2000;6:3614-20.
    • (2000) Clin Cancer Res , vol.6 , pp. 3614-3620
    • Florenes, V.A.1    Faye, R.S.2    Maelandsmo, G.M.3    Nesland, J.M.4    Holm, R.5
  • 64
    • 0035915806 scopus 로고    scopus 로고
    • Expression of Melan-A/Mart-1 antigen as a prognostic factor in primary cutaneous melanoma
    • Berset M, Cerottini JP, Guggisberg D, Romero P, Burri F, Rimoldi D et al. Expression of Melan-A/Mart-1 antigen as a prognostic factor in primary cutaneous melanoma. Int J Cancer 2001;95:73-7.
    • (2001) Int J Cancer , vol.95 , pp. 73-77
    • Berset, M.1    Cerottini, J.P.2    Guggisberg, D.3    Romero, P.4    Burri, F.5    Rimoldi, D.6
  • 65
    • 0029925375 scopus 로고    scopus 로고
    • Prognostic value of tumour infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
    • Clemente CG, Mihm MC, Bufalino R, Zurrida S, Colloni P, Cascinelli N. Prognostic value of tumour infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996;77:1303-10.
    • (1996) Cancer , vol.77 , pp. 1303-1310
    • Clemente, C.G.1    Mihm, M.C.2    Bufalino, R.3    Zurrida, S.4    Colloni, P.5    Cascinelli, N.6
  • 66
    • 0033009218 scopus 로고    scopus 로고
    • Thin cutaneous melanomas (< 1.5 mm). Identification of risk factors indicative of progression
    • Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M. Thin cutaneous melanomas (< 1.5 mm). Identification of risk factors indicative of progression. Cancer 1999;85:1067-78.
    • (1999) Cancer , vol.85 , pp. 1067-1078
    • Massi, D.1    Franchi, A.2    Borgognoni, L.3    Reali, U.M.4    Santucci, M.5
  • 67
    • 0031678829 scopus 로고    scopus 로고
    • Prognostic value of MMP-2 (72kD type IV collagenase) in primary skin melanoma
    • Vaisanen A, Kallionen M, Taskinen PJ, Turpeenniemi-Hujanen T. Prognostic value of MMP-2 (72kD type IV collagenase) in primary skin melanoma. J Pathol 1998;186:51-8.
    • (1998) J Pathol , vol.186 , pp. 51-58
    • Vaisanen, A.1    Kallionen, M.2    Taskinen, P.J.3    Turpeenniemi-Hujanen, T.4
  • 68
    • 0032982090 scopus 로고    scopus 로고
    • Osteonectin expression correlates with clinical outcome in thin cutaneous melanomas
    • Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M. Osteonectin expression correlates with clinical outcome in thin cutaneous melanomas. Hum Pathol 1999;30:339-44.
    • (1999) Hum Pathol , vol.30 , pp. 339-344
    • Massi, D.1    Franchi, A.2    Borgognoni, L.3    Reali, U.M.4    Santucci, M.5
  • 70
    • 0033952887 scopus 로고    scopus 로고
    • Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome
    • McDermott NC, Milburn C, Curran CM, Kay EW, Walsh CB, Leader MB. Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome. J Pathol 2000;190:157-62.
    • (2000) J Pathol , vol.190 , pp. 157-162
    • McDermott, N.C.1    Milburn, C.2    Curran, C.M.3    Kay, E.W.4    Walsh, C.B.5    Leader, M.B.6
  • 71
    • 0031772245 scopus 로고    scopus 로고
    • Prognostic factors for cutaneous melanoma
    • Wick MR. Prognostic factors for cutaneous melanoma. Am J Clin Pathol 1998;110:713-8.
    • (1998) Am J Clin Pathol , vol.110 , pp. 713-718
    • Wick, M.R.1
  • 72
    • 0035677699 scopus 로고    scopus 로고
    • High proliferative activity may predict early metastasis of thin melanoma
    • Frahm SO, Schubert C, Parwaresch R, Rudolph P. High proliferative activity may predict early metastasis of thin melanoma. Hum Pathol 2000;32:1376-81.
    • (2000) Hum Pathol , vol.32 , pp. 1376-1381
    • Frahm, S.O.1    Schubert, C.2    Parwaresch, R.3    Rudolph, P.4
  • 73
    • 0034038805 scopus 로고    scopus 로고
    • Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: An adjunct for recognition of the vertical growth phase in malignant melanoma
    • Kaleem Z, Lindt AC, Humphrey PA, Sueper RH, Swanson PE, Ritter JH et al. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanoma. Mod Pathol 2000;13:217-22.
    • (2000) Mod Pathol , vol.13 , pp. 217-222
    • Kaleem, Z.1    Lindt, A.C.2    Humphrey, P.A.3    Sueper, R.H.4    Swanson, P.E.5    Ritter, J.H.6
  • 74
    • 0344301855 scopus 로고    scopus 로고
    • Stochastic relationship between the growth fraction and vascularity of thin malignant melanoma
    • Pierard GE, Pierard-Franchimont C. Stochastic relationship between the growth fraction and vascularity of thin malignant melanoma. Eur J Cancer 1997;33:1888-92.
    • (1997) Eur J Cancer , vol.33 , pp. 1888-1892
    • Pierard, G.E.1    Pierard-Franchimont, C.2
  • 75
    • 0030893843 scopus 로고
    • Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer
    • Isaacs JT. Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 1977;150:1511-21.
    • (1977) Am J Pathol , vol.150 , pp. 1511-1521
    • Isaacs, J.T.1
  • 76
    • 0035845511 scopus 로고    scopus 로고
    • Gene expression patterns of breast carcinoma distinguish subclasses with potential clinical implications
    • Sorlie T, Perou CM, Tibshrani R, AasT, Geisler S, Johnsen H et al. Gene expression patterns of breast carcinoma distinguish subclasses with potential clinical implications. Proc Natl J Acad Sci 2001;98:10869-74.
    • (2001) Proc Natl J Acad Sci , vol.98 , pp. 10869-10874
    • Sorlie, T.1    Perou, C.M.2    Tibshrani, R.3    Aas, T.4    Geisler, S.5    Johnsen, H.6
  • 77
    • 0034931807 scopus 로고    scopus 로고
    • Molecular markers of metastasis in squamous cell carcinoma
    • Elliwell TR. Molecular markers of metastasis in squamous cell carcinoma. J Pathol 2001;194:289-93.
    • (2001) J Pathol , vol.194 , pp. 289-293
    • Elliwell, T.R.1
  • 78
    • 0035874979 scopus 로고    scopus 로고
    • A novel N-ras mutation in malignant melanoma is associated with excellent prognosis
    • Demunter A, Ahmadian MR, Libbrecht L, Stas M, Bains M, Schiffzek K et al. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis. Cancer Res 2001;61:4916-22.
    • (2001) Cancer Res , vol.61 , pp. 4916-4922
    • Demunter, A.1    Ahmadian, M.R.2    Libbrecht, L.3    Stas, M.4    Bains, M.5    Schiffzek, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.